ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Go back to ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results| Immucell Corp (NASDAQ: ICCC) | Delayed: 10.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.13 | 52 Week High | $8.29 | |||
| Open | $10.13 | 52 Week Low | $4.99 | |||
| Day High | $10.13 | P/E | 126.63 | |||
| Day Low | $10.13 | EPS | $0.08 | |||
| Volume | 957 | |||||

